2nd Annual Data Analytics and Decisions
January 23 - 24, 2019 - Philadelphia MA USCBI a division of UBM Americas
michael.berube@cbinet.com
Phone:339-298-2185
Advance Analytical Tools to Strengthen Compliance Programs and Enhance Business Intelligence CBI’s 2nd Annual Data Analytics and Decisions focuses on data analytics to make strategic business decisions that will strengthen compliance monitoring and improve commercial business performance. Currently, bio/pharmaceutical and device companies are focused on streamlining their data collection practices, determining the metrics to focus on, choosing how to visualize results and analyzing best practices to filter the results. This program offers the opportunity for those with a focus on analytics, monitoring, and IT to further discuss how to integrate new technologies into the decision making of bio/pharmaceutical and device companies. Key Insights and Takeaways: Discuss the increased use of data in analyzing trends for fraud and the use of data to identify outliers Strengthen risk management and business intelligence for third-party data Ensure comprehensive collection and reporting of accurate physician spend data for speaker programs Examine the story behind the data and how to shift your focus away from the results Discover how to improve systems for data remediation and validation Solidify an approach for cleaning internal data and analyzing external data Examine the different approaches when comparing US and Global data sets